A phase 3 study found that the 20-valent pneumococcal conjugate vaccine (PCV20) elicited strong immune responses across all 20 serotypes and had a safety profile comparable with PCV13.
A recent study examined how prior SARS-CoV-2 vaccination influences innate and adaptive immune responses in breakthrough infections, revealing distinct immune activation patterns.
A randomized trial comparing influenza vaccines over two seasons found that recombinant vaccines showed stronger immune responses to A/H3N2 strains compared with egg-based and cell culture-based vaccines. ...
In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...
This respiratory health roundup highlights the emerging links between lung and brain health in long COVID, rising avian flu cases in humans and animals, additional insights into the lasting health impacts...
The CDC has updated its guidelines for COVID-19 and pneumococcal vaccines, aiming to boost protection for high-risk populations against severe disease year-round.
Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.
In this COVID-19 roundup, the CDC reports a record low number of COVID-19 hospitalizations, metformin reduces the likelihood of SARS-CoV-2 Viral load and rebound, remdesivir reduces mortality in older...
This COVID-19 roundup includes coverage on the latest estimated number of adults with long COVID, WHO’s updated terminology for pathogens that transmit through the air, how COVID-19 vaccination reduces the...
The Advisory Committee on Immunization Practices released its updated annual immunization schedule for 2024 that includes new sections on respiratory syncytial virus (RSV), and the mpox (monkeypox) and...
